Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04591782 · ClinicalTrials.gov registry record · NA
Investigation of PJ vs. Sugar on Glucose Levels in Healthy and Prediabetic Subjects
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04591782 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 42 participants.
The verdict
NCT04591782, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Pomegranate fruits and products, including juice, tea, wine and extracts are widely consumed and recognized for their health benefits. Pomegranate fruit possesses strong antioxidant, anti-inflammatory and antiproliferative properties. The effects of pomegranate on type 2 diabetic (T2DM) conditions have previously been reported. Although 8 oz. of Pom juice (PJ) contains 36.9 g of sugar, 12-week PomJ supplementation did not change plasma advanced glycated end-products, fasting glucose and HbA1C, but reduced lipid peroxidation in T2D subjects. Additionally, acute PJ consumption has been shown to lower postprandial glycemic response of a meal with high glycemic index (GI) and lower fasting blood glucose, and long-term PomJ consumption did not worsen diabetic markers. However, a large knowledge gap still exists regarding the form of sugars in PJ and the hormonal responses to PJ consumption in different physiological conditions. Therefore currently the consumption of PJ is not recommended for individuals with T2DM. This clinical study will focus on the short-term effects of PJ consumption on different diabetic variables to further evaluate the health benefits of PJ for T2DM.
Interventions
- OTHER Water
- OTHER PomJuice
- OTHER Sugar Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2021-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04591782
The ClinicalTrials.gov registry entry for NCT04591782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Water is the first listed.
NCT04591782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04591782 about?
NCT04591782 is a clinical study titled "Investigation of PJ vs. Sugar on Glucose Levels in Healthy and Prediabetic Subjects". Pomegranate fruits and products, including juice, tea, wine and extracts are widely consumed and recognized for their health benefits. Pomegranate fruit possesses strong antioxidant, anti-inflammatory and antiproliferative properties. The effects of pomegranate on type 2 diabetic (T2DM) conditions h...
What is the current status of trial NCT04591782?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2019-02-01. Estimated completion is 2021-12-20.
What interventions are being tested in trial NCT04591782?
The interventions under investigation include: Water (OTHER), PomJuice (OTHER), Sugar Water (OTHER).
Who is sponsoring clinical trial NCT04591782?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.